Cancer Center News

In a wide-ranging article about the increasing number of cancer survivors, a CHOP expert discusses endocrine late effects of treatment.

In a HemOnc Today article, a CHOP expert discusses the existing guidelines covering monitoring survivors for endocrine late effects of treatment.

The strategy, developed by CHOP researchers, would help generate a vaccine that would protect people across the population.

Jake Orlick, an 11-year-old boy, is fighting a courageous battle against Ewing Sarcoma, a rare form of bone cancer. Our Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, may be on the verge of a breakthrough with a novel new experimental treatment for relapsed Ewing sarcoma.

Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, is set to launch a novel, experimental approach to treating relapsed Ewing sarcoma, as highlighted in this story in the Philadelphia Inquirer.

Caregiver burnout is not only normal, but inevitable. A CHOP psychologist offers advice for struggling families.

This case study highlights a multimodal approach to surgical management of osteosarcomas in young children, maximizing control while providing a functional limb that will grow with the child.

Patrick J. Grohar, MD, PhD, focuses on developing therapies for a cancer that’s rare in adults but relatively common in the pediatric population.

CHOP has opened a phase 1 trial using CAR T for tough acute myeloid leukemia, hoping to replicate the therapy’s success for acute lymphoblastic leukemia.

A CHOP program is focused on identifying children who are predisposed to develop cancer and using surveillance testing to detect cancers early.